Inhibition of Cyclooxygenase 2 Synthesis SuppressesHerpes simplexVirus Type 1 Reactivation
- 1 April 2005
- journal article
- Published by Mary Ann Liebert Inc in Journal of Ocular Pharmacology and Therapeutics
- Vol. 21 (2) , 114-120
- https://doi.org/10.1089/jop.2005.21.114
Abstract
Recurrent herpes virus infection, in which the virus reactivates from the nervous system and causes painful lesions in peripheral tissues, is a significant clinical problem. Our recent studies showing that the amount of cyclooxygenase 2 (COX-2) in the trigeminal ganglia of heat-stressed untreated mice is higher than the amount in heat-stressed mice treated with the COX-2 inhibitor, celecoxib, have indicated that the prostaglandin synthesis pathway--and in particular COX-2--may be an intermediate in the pathway to herpes viral reactivation. To further study this process, we infected the corneas of mice using topical application to a lightly scratched epithelium and waited 30 days for Herpes simplex virus type 1 (HSV-1) latency to be established in the trigeminal ganglia. Prior to the induction of viral reactivation, the mice were treated orally with celecoxib. Treated and untreated mice were induced to undergo reactivation by immersion in 43 degrees C water for 10 min. The shedding of virus at the ocular surface was determined by culturing ocular swabs with indicator cells. The presence of infectious virus in the trigeminal ganglion was evaluated by incubating ganglion homogenates with indicator cells and observing for cytopathic effect. Celecoxib treatment significantly suppressed viral reactivation when given prophylactically by the gastrointestinal route. The numbers of corneas and ganglia containing infectious virus were significantly lower in the celecoxib-treated animals, compared to the placebo-treated mice. These experiments demonstrate that a selective COX-2 inhibitor can suppress hyperthermic stress-induced herpes viral reactivation in the nervous system. It may be possible to use COX-2 inhibitors to prevent viral reactivation in high-risk patients by drug prophylaxis.Keywords
This publication has 41 references indexed in Scilit:
- Acetylsalicylic acid reduces viral shedding induced by thermal stressCurrent Eye Research, 2004
- The Effects of Xalatan® On the Recovery of Ocular Herpes Simplex Virus Type 1 (HSV-1) in the Induced Reactivation and Spontaneous Shedding Rabbit ModelsJournal of Ocular Pharmacology and Therapeutics, 2003
- Molecular nanosprings in spider capture-silk threadsNature Materials, 2003
- 9-(4-hydroxybutyl)-N2-phenylguanine (HBPG), a thymidine kinase inhibitor, suppresses herpes virus reactivation in miceAntiviral Research, 1996
- Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.British Journal of Ophthalmology, 1996
- Propranolol suppresses reactivation of herpesvirusAntiviral Research, 1995
- The Natural History of Ultraviolet Radiation-Induced Herpes Simplex Labialis and Response to Therapy with Peroral and Topical Formulations of AcyclovirThe Journal of Infectious Diseases, 1991
- Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration.British Journal of Ophthalmology, 1986
- Inhibition by Indomethacin of in vitro Reactivation of Latent Herpes Simplex Virus Type 1 in Murine Trigeminal GangliaJournal of General Virology, 1984
- AN ALTERNATIVE THEORY OF HERPES-SIMPLEX RECURRENCE AND A POSSIBLE ROLE FOR PROSTAGLANDINSThe Lancet, 1976